These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24798009)

  • 41. The cytolytic C5b-9 complement complex: feedback inhibition of complement activation.
    Bhakdi S; Maillet F; Muhly M; Kazatchkine MD
    Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1912-6. PubMed ID: 3162317
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The mystery behind membrane insertion: a review of the complement membrane attack complex.
    Bayly-Jones C; Bubeck D; Dunstone MA
    Philos Trans R Soc Lond B Biol Sci; 2017 Aug; 372(1726):. PubMed ID: 28630159
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Distinct localization of the complement C5b-9 complex on Gram-positive bacteria.
    Berends ET; Dekkers JF; Nijland R; Kuipers A; Soppe JA; van Strijp JA; Rooijakkers SH
    Cell Microbiol; 2013 Dec; 15(12):1955-68. PubMed ID: 23869880
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The complement system].
    Taran LD
    Biokhimiia; 1993 May; 58(5):780-7. PubMed ID: 8338890
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural basis of complement membrane attack complex formation.
    Serna M; Giles JL; Morgan BP; Bubeck D
    Nat Commun; 2016 Feb; 7():10587. PubMed ID: 26841837
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Freeze-thaw activation of the complement attack phase: II. Comparison of convertase generated C--56 with C--56 generated by freezing and thawing.
    Dessauer A; Rother U; Rother K
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():83-8. PubMed ID: 6444196
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human peritoneal macrophages. Production in vitro of the active terminal complement components C5 to C9 and a functional alternative pathway of complement. Brief report.
    Hetland G; Bungum L
    APMIS; 1988 Jan; 96(1):89-92. PubMed ID: 3345254
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.
    Rollins SA; Sims PJ
    J Immunol; 1990 May; 144(9):3478-83. PubMed ID: 1691760
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Formation of the membrane attack complex of complement (MAC) on erythrocytes from monocyte-produced terminal complement components.
    Hetland G; Johnson E; Eskeland T
    Scand J Immunol; 1987 Jun; 25(6):571-7. PubMed ID: 3602934
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chimeric and truncated forms of human complement protein C8 alpha reveal binding sites for C8 beta and C8 gamma within the membrane attack complex/perforin region.
    Plumb ME; Scibek JJ; Barber TD; Dunlap RJ; Platteborze PL; Sodetz JM
    Biochemistry; 1999 Jun; 38(26):8478-84. PubMed ID: 10387094
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CryoEM reveals how the complement membrane attack complex ruptures lipid bilayers.
    Menny A; Serna M; Boyd CM; Gardner S; Joseph AP; Morgan BP; Topf M; Brooks NJ; Bubeck D
    Nat Commun; 2018 Dec; 9(1):5316. PubMed ID: 30552328
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Streptococcus pneumoniae phosphoglycerate kinase is a novel complement inhibitor affecting the membrane attack complex formation.
    Blom AM; Bergmann S; Fulde M; Riesbeck K; Agarwal V
    J Biol Chem; 2014 Nov; 289(47):32499-511. PubMed ID: 25281746
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structure, function and control of complement C5 and its proteolytic fragments.
    Laursen NS; Magnani F; Gottfredsen RH; Petersen SV; Andersen GR
    Curr Mol Med; 2012 Sep; 12(8):1083-97. PubMed ID: 22812419
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The C5b-9 complex: subunit composition of the classical and alternative pathway-generated complex.
    Podack ER; Kolb WP; Muller-Eberhard HJ
    J Immunol; 1976 May; 116(5):1431-4. PubMed ID: 1270802
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Membrane pore formation by human complement: functional importance of the transmembrane β-hairpin (TMH) segments of C8α and C9.
    Weiland MH; Qian Y; Sodetz JM
    Mol Immunol; 2014 Feb; 57(2):310-6. PubMed ID: 24239861
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae.
    Densen P; McRill CM; Ross SC
    J Immunol; 1988 Dec; 141(11):3902-9. PubMed ID: 3141507
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Crystal structure of the MACPF domain of human complement protein C8 alpha in complex with the C8 gamma subunit.
    Slade DJ; Lovelace LL; Chruszcz M; Minor W; Lebioda L; Sodetz JM
    J Mol Biol; 2008 May; 379(2):331-42. PubMed ID: 18440555
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sublytic complement attack exposes C-reactive protein binding sites on cell membranes.
    Li YP; Mold C; Du Clos TW
    J Immunol; 1994 Mar; 152(6):2995-3005. PubMed ID: 8144898
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Studies on the mechanism of bacterial resistance to complement-mediated killing. III. C5b-9 deposits stably on rough and type 7 S. pneumoniae without causing bacterial killing.
    Joiner K; Brown E; Hammer C; Warren K; Frank M
    J Immunol; 1983 Feb; 130(2):845-9. PubMed ID: 6848598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.